SMAD4 and hepatocellular carcinoma: These findings are consistent with recent study demonstrating that MyD88 expression levels affect Smad4 protein levels in Hub7 hepatoma cells through the Toll/IL-1 receptor domain of the MyD88 protein (Samba-Mondonga et al., 2018).